Tale of Constant Adaptation, Revision, and Change of Cancer Therapy during the Ongoing COVID Crisis: Adapting to Cope and Win

Rima Pathak; Garvit Chitkara; Padmaj Kulkarni; Gouri Shankar Bhattacharyya; Sudeep Gupta; Jyoti Bajpai

doi:10.4103/ijmpo.ijmpo_162_20

Indian Journal of Medical and Paediatric Oncology, Table of Contents

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(02): 103-109
DOI: 10.4103/ijmpo.ijmpo_162_20

Editorial Commentary

Tale of Constant Adaptation, Revision, and Change of Cancer Therapy during the Ongoing COVID Crisis: Adapting to Cope and Win

Authors

Rima Pathak

Department of Radiation Oncology, Tata Memorial Centre, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India
Garvit Chitkara

Department of Surgical Oncology, Tata Memorial Centre, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India
Padmaj Kulkarni

Department of Medical Oncology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India
Gouri Shankar Bhattacharyya

Department of Medical Oncology, Salt Lake City Medical Centre, Kolkata, West Bengal, India
Sudeep Gupta

Department of Medical Oncology, Tata Memorial Centre, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India
Jyoti Bajpai

Department of Medical Oncology, Tata Memorial Centre, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India

Abstract

Full Text

References

References
1 Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; [Online ahead of print]
2 Kant L, Guleria R. Pandemic Flu, 1918: After hundred years, India is as vulnerable. Indian J Med Res 2018; 147: 221
3 Management of Patients with Confirmed 2019-nCoV. CDC. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html Available from: [Last accessed on 2020 Apr 09]
4 European Centre for Disease Prevention and Control. Considerations Relating to Social Distancing Measures in Response to COVID-19 – Second Update. Stockholm; 2020. https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-social-distancing-measuresg-guide-second-update.pdf Available from: [Last accessed on 2020 Apr 09]
5 World Health Organization. Managing Epidemics: Key Facts about Major Deadly Diseases. https://www.who.int/emergencies/diseases/managing-epidemics-interactive.pdf Available from: [Last accessed on 2020 Apr 09]
6 Kwok KO, Lai F, Wei WI, Shan Wong SY, Tang JW. Herd immunity – Estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect 2020; 80: e32-3
7 Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: Prioritizing treatment during a global pandemic. Nat Rev Clin Oncol 2020; 17: 268-70
8 Lewis MA. Between Scylla and Charybdis – Oncologic decision making in the time of Covid-19. N Engl J Med 2020; pii: 2006588
9 Shearer FM, Moss R, McVernon J, Ross JV, McCaw JM. Infectious disease pandemic planning and response: Incorporating decision analysis. PLoS Med 2020; 17: e1003018
10 Tsang J, Bajpai J. Novel coronavirus infection – Knowns and unknowns with particular reference to oncology – Combating against COVID-19 with “COVID.”. Indian J Med Paediatr Oncol 2020; 41: 108-20
11 Chandra S, Kassens-Noor E. The evolution of pandemic influenza: Evidence from India, 1918-19. BMC Infect Dis 2014; 14: 510
12 Shankar A, Saini D, Roy S. et al. Cancer Care Delivery Challenges Amidst Coronavirus Disease-19 (COVID-19) Outbreak: Specific Precautions for Cancer Patients and Cancer Care Providers to Prevent Spread. [Internet] Asian Pac J Cancer Prev 2020; 21: 569-73
13 National Health Service United Kingdom. NHS England's Clinical Guide for the Management of Cancer Patients during the Coronavirus Pandemic. https://www.england.nhs.uk/coronavirus/cancer/ Available from: [Last accessed on 2020 Apr 09]
14 Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020; 21: e180
15 Liang W, Guan W, Chen R, Wang W, Li J, Xu K. et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol 2020; 21: 335-7
16 COVID-19 Provider and Practice Information. ASCO. https://www.asco.org/asco-coronavirus-information/provider-practice-preparedness-covid-19 Available from: [Last accessed on 2020 Apr 09]
17 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395: 1054-62
18 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: Summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA - J Am Med Assoc 2020; 323: 1239-42
19 Supporting Oncology Professionals. ESMO. https://www.esmo.org/covid-19-and-cancer/supporting-oncology-professionals Available from: [Last accessed on 2020 Apr 09]
20 Lambertini M, Toss A, Passaro A, Criscitiello C, Cremolini C, Cardone C. et al. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists' perspective. ESMO Open 2020; 5: e000759
21 You B, Ravaud A, Canivet A, Ganem G, Giraud P, Guimbaud R. et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol 2020; 21: 619-21
22 National Institute of Health and Care Excellence. Overview | COVID-19 Rapid Guideline: Delivery of Systemic Anticancer Treatments | Guidance | NICE. NICE; 2020. https://www.nice.org.uk/guidance/ng161 Available from: [Last accessed on 2020 May 26]
23 The American Cancer Society Cancer Action Network. COVID-19 Pandemic Impact on Cancer Patients and Survivors Survey Findings Summary; 2020. https://www.kff.org/other/state-indicator/total-population/ Available from: [Last accessed on 2020 Apr 19]
24 American Society of Clinical Oncology. COVID-19 Patient Care Information. American Society of Clinical Oncology; 2020. https://www.asco.org/asco-coronavirus-information/care-individuals-cancer-during-covid-19 Available from: [Last accessed on 2020 Apr 19]
25 Oxford Economics/ Haver Analytics. Global Analysis of Health Insurance in India. https://www.ey.com/Publication/vwLUAssets/EY-global-analysis-of-health-insurance-in-india/$File/ey-global-analysis-of-health-insurance-in-india.pdf [Last accessed 2020 Apr 19]
26 Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol 2020; 21: 629-30
27 Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol 2020; 31: 553-5
28 COVID-19 Rapid Guideline: Delivery of Radiotherapy. NICE 2020
29 Q and A on Coronaviruses (COVID-19). https://www.who.int/news-room/q-a-detail/q-a-coronaviruses Available from: [Last accessed on 2020 Apr 09]
30 Wei W, Zheng D, Lei Y, Wu S, Verma V, Liu Y. et al. Radiotherapy workflow and protection procedures during the coronavirus disease 2019 (COVID-19) outbreak: Experience of the Hubei cancer hospital in Wuhan, China. Radiother Oncol 2020; 148: 203-10
31 Simcock R, Thomas TV, Mercy CE, Filippi AR, Katz MA, Pereira IJ. et al. COVID-19: Global radiation oncology's targeted response for pandemic preparedness. Clin Transl Radiat Oncol 2020; 22: 55-68
32 Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D. et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol 2020; pii S0167-8140 (20) 30182-1
33 Ministry of Health and Family Welfare DG of HS. Novel Coronavirus Disease 2019 (COVID-19): Guidelines on Rational Use of Personal Protective Equipment. https://www.mohfw.gov.in/pdf/GuidelinesonrationaluseofPersonalProtectiveEquipment.pdf Available from: [Last accessed 2020 May 26]
34 Mailankody S, Bajpai J. Intelligent adaptation to the changing surroundings amidst the COVID-19 pandemic for sarcomas and melanomas. Cancer Res Stat Treat 2020; 3 Suppl S1 110-4
35 Department of Health Research IC of MR. Strategy for COVID19 Testing in India; 2020. https://icmr.nic.in/sites/default/files/upload_documents/Strategey_for_COVID19_Test_v4_09042020.pdf Available from: [Last accessed on 2020 Apr 20]
36 National Comprehensive Cancer Network. Coronavirus Disease 2019 (COVID-19) Resources for the Cancer Care Community; 2020. https://www.nccn.org/covid-19/ Available from: [Last accessed on 2020 Apr 10]
37 Kulkarni P, Dhanushkodi M. Novel coronavirus severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019): We shall overcome!. Indian J Med Paediatr Oncol 2020; 41: 103-6
38 Slater H. ACS Guidelines for Cancer Surgeries During COVID-19 Epidemic; 2020.
39 Gemici C, Yaprak G. Covid-19 outbreak in a major radiation oncology department; which lessons should be taken?. Radiother Oncol 2020; [Epub ahead of print]
40 Shuryak I, Hall EJ, Brenner DJ. Optimized hypofractionation can markedly improve tumor control and decrease late effects for head and neck cancer. Int J Radiat Oncol Biol Phys 2019; 104: 272-8
41 Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ. et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 2020; 181: 487